ÂÜÀòÂÒÂ×

John Miller was appointed to senior vice president, corporate strategy in October, 2022. He was previously senior vice president of global product strategy and program management, after serving as vice president of global product strategy. Prior to that, Mr. Miller held various management roles within the oncology therapeutic area. He is currently responsible for leading corporate strategy and portfolio management, defining therapeutic and disease areas of interest to guide corporate development and R&D strategies and driving long-range planning.